Open access · OA
via Europe PMC
Chasing the FoxO in Metabolic Disorders: Novel Considerations for Oxidative Stress, Programmed Cell Death, Wnt, and the Gut Microbiome.
Antioxidants (Basel, Switzerland) · 2026
Telomere attrition
Dysbiosis
Cellular senescence
Altered intercellular communication
Disabled macroautophagy
Rapamycin / mTOR inhibition
Human
Abstract
Lifespan is increasing throughout the world leading to a rise in non-communicable diseases in the global population that impacts over 800 million individuals with metabolic disorders, such as diabetes mellitus. Metabolic disease presents a significant challenge for clinical care since multi-organ disease progression ensues despite a broad array of treatment protocols. The pursuit of innovative strategies with mammalian forkhead transcription factors of the "O" class (FoxOs) and intimately related pathways of aging, cellular senescence(definition), telomere(definition) integrity, oxidative stress, programmed cell death with apoptosis, autophagy(definition), ferroptosis, pyroptosis, and cuproptosis, Wnt/β-catenin signaling, Wnt1 inducible signaling pathway protein 1, and the gut microbiome becomes vital to address the clinical hurdles of metabolic disorders. Platforms incorporating novel diagnostics with artificial intelligence and machine learning can further address the underlying mechanisms tied to FoxOs that include the mechanistic target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition), AMP activated protein kinase, silent mating type information regulation 2 homolog 1 (<i>S. cerevisiae</i>), and glucagon-like peptide-1 receptor agonists that can markedly influence biological outcomes. Given the premise that it is essential to comprehend the intimate relationship that FoxO signaling pathways hold, FoxOs offer an exciting and promising approach to address the clinical aspects of disease onset, progression, and treatment with metabolic disorders.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.3390/antiox15070895
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
K., M. (2026). Chasing the FoxO in Metabolic Disorders: Novel Considerations for Oxidative Stress, Programmed Cell Death, Wnt, and the Gut Microbiome. <em>Antioxidants (Basel, Switzerland)</em>. https://doi.org/10.3390/antiox15070895
Vancouver
K. M. Chasing the FoxO in Metabolic Disorders: Novel Considerations for Oxidative Stress, Programmed Cell Death, Wnt, and the Gut Microbiome. Antioxidants (Basel, Switzerland). 2026. doi:10.3390/antiox15070895.
BibTeX
@article{maiese2026Chasin,
title = {Chasing the FoxO in Metabolic Disorders: Novel Considerations for Oxidative Stress, Programmed Cell Death, Wnt, and the Gut Microbiome.},
author = {Maiese K.},
journal = {Antioxidants (Basel, Switzerland)},
year = {2026},
doi = {10.3390/antiox15070895},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
International review of neurobiology 2026
Citation only
Running out the clock: Circadian rhythm dysfunction in cognitive disease.
Cells 2023
Open access · CC-BY
Cornerstone Cellular Pathways for Metabolic Disorders and Diabetes Mellitus: Non-Coding RNAs, Wnt Signaling, and AMPK
Aging advances 2026
Open access · OA
Dementia, mood disorders, and aging: Bridging new avenues of care through shared biological pathways.
Expert review of clinical pharmacology 2026
Citation only
Osteoarthritis and dementia: contrasting disorders driven by mutual pathways of autophagy, mTOR, GLP-1, AMPK, Wnt, and WISP1.
Current Neurovascular Research 2017
Preprint · OA
Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer
Innovation in Aging 2024
Open access · CC-BY